/Berkshire%20Hathaway%20Inc_%20%20logo%20and%20money%20background-%20by%20photo_gonzo%20via%20Shutterstock.jpg)
In Tuesday trading, Davita (DVA), a leading provider of dialysis services, and Berkshire Hathaway’s (BRK.B) 16th-largest holding, hit its 23rd new 52-week low of the past 12 months at $104.24.
Down 37% over the past year, newly-appointed CEO Greg Abel could be looking to accelerate the holding company’s sale of Davita stock as we hit the midway point of 2026’s first month.